Viking Therapeutics (NASDAQ: VKTX) is operating in one of the highest-growth pharma areas around. Viking doesn't sell weight ...

Lariocidin was efficient against strains of E. coli, including drug-resistant ones, according to the new study.

With new tariffs set to take effect on Liberation Day, the move is sending shockwaves across multiple industries. The noise ...

Indivior, leader in opioid treatment, trades near 52-week lows. Read more on INDV stock's financials, growth challenges, and ...

Currently, all drug-eluting stents (DES), used to treat blocked heart arteries, are priced at Rs 35,000. The Indian Express ...

Perhaps the Tuesday pharma sell-off was mitigated by indications Trump and his team might be amenable to either a softer or more gradual approach to industry tariffs. That bearishness about the ...

President Donald Trump's proposed tariffs could raise the cost of some cancer treatments by as much as $10,000, while also ...

Drugmakers are pushing back against pharmaceutical tariffs. Some companies are lobbying the Trump administration to phase in ...

Takeda boosts profit margins with AI-driven growth, FY2024 guidance upgrade, share buyback plan & promising drug launches.

Leerink Partners analyst David Resinger warned his clients on Sunday that the tariff risks to the industry are ...

Pfizer’s (PFE) stock has fallen ill since the COVID-19 pandemic waned, and it is still experiencing some aftereffects. The ...